Related Experiment Video
Updated: Sep 22, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Study on the Function and Mechanism of miR-585-3p Inhibiting the Progression of Ovarian Cancer Cells by Targeting
Yiming Jia1, Jingru Li1, Jinfeng Wang1
1Department of Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin City, Heilongjiang Province 150001, China.
Abstract:
Ovarian cancer (OC) is the leading cause of death for women diagnosed with gynecological cancer. Studies have shown that dysregulated miRNA expression is related to various cancers, including OC. Here, we aimed to explore the biological function and mechanism of miR-585-3p in the occurrence and development of OC. The expression level of miR-585-3p was found to be low in OC tissues and cells. We analyzed the biological function of miR-585-3p in OC through in vitro cell experiments. The results indicated that overexpression of miR-585-3p inhibited the proliferation, invasion, and migration of SW626 cells, while low expression of miR-585-3p had the opposite effect in SKOV3 cells. We then screened the target genes of miR-585-3p through miRDB database and detected the expression of target genes in OC cells. FSCN1 was found to be most significantly upregulated in OC cells. Dual-luciferase reporter assays revealed FSCN1 as a potential target of miR-585-3p. Western blot analysis showed that miR-585-3p targeted FSCN1 to inhibit protein phosphorylation of ERK. In vivo animal experiments also confirmed that miR-585-3p targets FSCN1 to inhibit tumor growth and block the MAPK signaling pathway. In summary, miR-585-3p inhibits the proliferation, migration, and invasion of OC cells by targeting FSCN1, and its mechanism of action may be achieved by inhibiting the activation of the MAPK signaling pathway. miR-585-3p may serve as a potential biomarker and therapeutic target for OC.
Insights
MicroRNA-585-3p (miR-585-3p) is downregulated in ovarian cancer (OC). Restoring miR-585-3p levels inhibits OC cell proliferation and invasion by targeting FSCN1 and the MAPK pathway, suggesting its therapeutic potential.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Ovarian cancer (OC) is a leading cause of cancer death in women.
- Dysregulated microRNA (miRNA) expression is implicated in various cancers, including OC.
- The specific role of miR-585-3p in OC development requires further investigation.
Purpose of the Study:
- To investigate the biological function and molecular mechanism of miR-585-3p in ovarian cancer.
- To determine the expression levels of miR-585-3p in OC tissues and cells.
- To identify target genes and signaling pathways regulated by miR-585-3p in OC.
Main Methods:
- In vitro cell proliferation, invasion, and migration assays.
- Bioinformatic screening of miR-585-3p target genes using miRDB.
- Dual-luciferase reporter assays and Western blot analysis.
- In vivo animal experiments to assess tumor growth and pathway modulation.
Main Results:
- miR-585-3p expression is significantly downregulated in OC tissues and cells.
- Overexpression of miR-585-3p suppressed OC cell proliferation, invasion, and migration.
- FSCN1 was identified as a direct target of miR-585-3p, and its upregulation in OC was confirmed.
- miR-585-3p inhibits ERK phosphorylation and blocks the MAPK signaling pathway by targeting FSCN1.
- In vivo studies confirmed that miR-585-3p inhibits tumor growth via FSCN1 and the MAPK pathway.
Conclusions:
- miR-585-3p functions as a tumor suppressor in ovarian cancer.
- The miR-585-3p/FSCN1 axis regulates OC cell behavior and the MAPK signaling pathway.
- miR-585-3p holds promise as a potential diagnostic biomarker and therapeutic target for ovarian cancer.
Related Concept Videos
MicroRNAs
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
MAPK Signaling Cascades
Abnormal Proliferation

